HEMATOLOGICAL SIDE-EFFECTS OF PYRIMETHAMINE IN THE TREATMENT OF OCULAR TOXOPLASMOSIS.
D000740:Anemia; D000748:Anemia, Macrocytic; D001792:Blood Platelets; D004358:Drug Therapy; D005492:Folic Acid; D006452:Hemoglobinometry; D006801:Humans; D002955:Leucovorin; D007958:Leukocyte Count; D008660:Metabolism; D009205:Myocarditis; D010859:Pigmentation Disorders; D011693:Purpura; D011696:Purpura, Thrombocytopenic; D011739:Pyrimethamine; D013449:Sulfonamides; D013921:Thrombocytopenia; D014116:Toxicology; D014123:Toxoplasmosis; D014126:Toxoplasmosis, Ocular
D013449:Sulfonamides; D005492:Folic Acid; D002955:Leucovorin; D011739:Pyrimethamine
ANEMIA, MACROCYTIC; BLOOD PLATELETS; CITROVORUM FACTOR; DRUG THERAPY; FOLIC ACID; HEMOGLOBINOMETRY; LEUKOCYTE COUNT; METABOLISM; MYOCARDITIS; PIGMENTATION DISORDERS; PURPURA, THROMBOPENIC; PYRIMETHAMINE; SULFONAMIDES; TOXICOLOGIC REPORT; TOXOPLASMOSIS, OCULAR